CD40 antibody as an adjuvant induces enhanced T cell responses

Carlring, J., Barr, T.A., McCormick, A.L. and Heath, A.W. (2004) CD40 antibody as an adjuvant induces enhanced T cell responses. Vaccine, 22(25-26), pp. 3323-3328. (doi:10.1016/j.vaccine.2004.02.043)

Full text not currently available from Enlighten.


Monoclonal antibodies against CD40, conjugated to antigen, act as potent immunological adjuvants for primary antibody responses. We show here that CD40mAbs can also act as strong adjuvants for memory antibody responses, and for T cell responses as measured by ex vivo T cell proliferation to antigen, and delayed type hypersensitivity. Interferon gamma secretion in response to antigen is also enhanced. Finally, the adjuvant effect of CD40mAbs for secondary antibody responses is transferred with T cells rather than B cells. CD40mAb apparently have potent adjuvant effects on both Th1-like cells, and on T cells able to promote B cell antibody production. It is possible that the adjuvant effects of CD40 are mediated at least in part, indirectly, through enhanced antigen presentation by specific B cells, to T cells.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Barr, Dr Tom
Authors: Carlring, J., Barr, T.A., McCormick, A.L., and Heath, A.W.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Vaccine

University Staff: Request a correction | Enlighten Editors: Update this record